GPCR/G protein


All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
-
A4653 Pimavanserin hemitartrateSummary: A potent 5-HT2A receptor inverse agonist for neuropsychiatric disorders -
A4654 Ketanserin tartrateSummary: A selective 5-HT2 receptor antagonist and hERG current inhibitor -
A4655 Lumateperone tosylateSummary: A 5-HT2A receptor antagonist for schizophrenia with potential anticancer activity -
A4656 Tandospirone citrateSummary: A selective 5-HT1A receptor agonist for depression and anxiety -
A4657 Jatrorrhizine chlorideSummary: A natural alkaloid that selectively inhibits AChE and reduces 5-HT and NE uptake -
A4659 Vabicaserin hydrochlorideSummary: A selective 5-HT2C receptor agonist for neuropsychiatric disorders -
A4711 Tetrahydro-β-carbolineSummary: A neuroactive β-carboline alkaloid derivative -
A4744 PCPA methyl ester hydrochlorideSummary: A reversible tryptophan hydroxylase inhibitor that lowers central 5-HT levels -
A4798 Naftidrofuryl oxalateSummary: A 5-HT2 receptor antagonist for peripheral and cerebral vascular diseases -
A8974 G-Protein antagonist peptide TFASummary: A polypeptide antagonist that specifically blocks GPCR-G protein interaction

